Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2026-01-17 Regulatory Filings
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Credit Rating- Others
Regulatory Filings Classification · 91% confidence The document is an official disclosure made under Regulation 30 of the SEBI Listing Regulations to BSE and NSE, informing the exchanges of a credit rating withdrawal by CRISIL following amalgamation. It is not a full annual or interim report, nor a management discussion, nor a financing transaction, but a required regulatory announcement under listing obligations. There is no category for credit ratings per se, so it falls into the fallback category for general regulatory announcements: Regulatory Filings (RNS).
2026-01-17 English
Pursuant to Composite scheme of Amalgamation and on request of the Company , Crisil Limited has withdrawn the rating assigned to the various credit facilities availed by Symed Labs Ltd
Regulatory Filings Classification · 85% confidence The document is an intimation under Regulation 30 of the SEBI Listing Regulations notifying stock exchanges of a credit rating withdrawal by Crisil following corporate amalgamation. It contains an official regulatory disclosure and press release text, not a financial report (such as an earnings release or interim report) nor a presentation. It is not merely a brief “report publication announcement” but a compliance filing under listing rules. This fits the “Regulatory Filings” category.
2026-01-17 English
Name Change
Regulatory Filings Classification · 95% confidence The document is an official letter addressed to stock exchanges informing them about the change of the company's name from Sequent Scientific Limited to Viyash Scientific Limited. It references regulatory compliance under SEBI Listing Regulations and includes details about the approval from the Registrar of Companies and the issuance of a new Certificate of Incorporation. The document is an intimation or announcement regarding a corporate action (name change) rather than a financial report, audit, or management discussion. It does not contain financial data or detailed report content but serves as a regulatory announcement to the stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-09 English
Intimation of Change of name of the Company
Regulatory Filings Classification · 80% confidence The document is a brief stock exchange intimation under Regulation 30 of SEBI Listing Regulations notifying a change of company name and enclosing a ROC Certificate of Incorporation. It does not contain substantive financial statements, proxy materials, or full reports but is a generic regulatory announcement, fitting the fallback category for miscellaneous regulatory filings.
2026-01-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialized/rematerialized for the period ended December 31, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar. The document is short (2533 characters) and serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities and share transfer details. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2026-01-09 English
Please find enclosed
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialized/rematerialized for the period ended December 31, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar. The document is short (2533 characters) and serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities and share transfer agent activities. Therefore, it fits best under Regulatory Filings (RNS) as a compliance certificate filing.
2026-01-09 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.